Healthcare Private Equity Firms in North America

223 investors found

Browse 223 Healthcare Private Equity Firms in North America. Discover top investors, their portfolios, AUM, and investment focus on InforCapital.

1932 Capital Management

1932 Capital Management

InvestorUnited States

1932 Capital Management is a single-family office established in 2019 by the Brown family, focusing on strategic investments in family and founder-owned businesses across North America. The firm employs a long-term investment approach with patient capital, seeking to partner with companies that align with its entrepreneurial spirit and core values of integrity, family, and people. Their investment strategies encompass control, minority, and venture-stage investments, demonstrating flexibility in their engagement with portfolio companies.The roots of the Brown family's business legacy trace back to 1932, when Israel Brown founded National Freight, which has since evolved into NFI, a prominent North American third-party logistics company with over 18,000 employees. This multi-generational entrepreneurial background, spanning over 90 years, has informed the family's extensive experience in owning, operating, and investing in closely held businesses, ultimately leading to the formation of 1932 Capital Management. The firm views itself as operators at heart, prioritizing the well-being of each business and its people.While the firm's website indicates over 100 investments in closely held companies, specific portfolio companies are not publicly detailed. Their venture investing arm, NFI Ventures, specifically targets early-stage companies driving innovation and disruption within the supply chain and logistics industry. Minority investments are opportunistic and flexible, spanning various sectors and company stages, including consumer technologies, food & beverage, hospitality, retail, industrials, and other dynamic industries. They partner with innovative entrepreneurs directly or support experienced sponsors.The firm's leadership includes Jared Szychter, who leads 1932 Capital Management and collaborates with the fourth generation of the Brown family to oversee NFI Ventures. This blend of family legacy and dedicated leadership brings a unique operational expertise and a collaborative, patient approach to their investments, aiming for long-term success for their portfolio companies.

2M Companies

2M Companies

InvestorUnited States

2M Companies is a family-led investment and philanthropic organization founded by Morton H. Meyerson. The firm operates with a core humanitarian principle: to help others, promoting dignity, equity, and a healthy mind, body, and spirit. These values guide their investment decisions, the people they collaborate with, and the relationships they foster. They actively seek creative solutions to contemporary challenges, applying original ideas to the complexities of the human experience.The firm's roots are deeply intertwined with Morton H. Meyerson's distinguished career as an entrepreneur and innovator, particularly his pioneering roles in technology services at companies like Electronic Data Systems, EDS/General Motors, Perot Systems, and duPont Glore Forgan. Today, he and his family oversee a network of organizations designed to channel private capital towards the creation of social good. This commitment is reflected in their belief in "virtuous cycles," where profits from their businesses and investments are shared with employees and communities, directly supporting their philanthropic foundations.2M Companies has a broad investment history spanning over 35 years, encompassing hundreds of investments. Their portfolio includes companies such as Lucidchart, Picmonic, Cognition Therapeutics, Answers, and Rackspace. The firm focuses on early-stage investments, typically participating in Seed and Series A rounds, with a strong emphasis on technological entrepreneurship and sectors that align with their social impact mission.The leadership team includes Morton Meyerson, Marti Meyerson, and Ian Trumpower, alongside other key personnel like Steve Leeke, Sharon Shoham, Trevor Cohen, and Antonio Perez. The firm's operations are closely linked to the Morton H. Meyerson Family Foundation and the Marlene Nathan Meyerson Family Foundation, which pursue Tzedakah projects focused on assisting underserved communities, providing access to basic human needs, and supporting Jewish organizations and programs.

2PointZero

2PointZero

InvestorUnited Arab Emirates36.2B AUM

2PointZero Group PJSC is a next-generation investment powerhouse based in Abu Dhabi, United Arab Emirates. The firm focuses on two multi-trillion-dollar sectors: Energy and Consumer, which are fundamental to everyday life and the new economy. Leveraging an AI-enabled, diversified portfolio, 2PointZero aims for efficiency, synergy, and compounding returns, driving sustainable growth through disciplined capital allocation, operational excellence, and digital integration. The firm's investment strategy is global, seeking opportunities to catalyze profitable growth through technology across its various business verticals.The current entity, 2PointZero Group PJSC, was formed in 2023 through a significant consolidation of major Abu Dhabi platforms, including Multiply Group and Ghitha Holding, under the umbrella of International Holding Company (IHC). The company officially changed its name from Multiply Group PJSC to Two Point Zero Group P.J.S.C in November 2025. This strategic restructuring aimed to create a robust and diversified investment platform with substantial assets, positioning it for transformative impact globally.2PointZero has made several notable investments and acquisitions. In March 2026, the firm completed a majority acquisition in Italy-based ISEM Packaging Group, a leading European packaging company serving luxury, beauty, and food sectors. The same month, its subsidiary IRH secured a 20-year LNG supply from Mexico's AMIGO LNG Project, and the group invested in WHOOP's Series G financing, a prominent consumer health and wellness technology platform. Additionally, 2PointZero acquired a 100% stake in Traverse Midstream Partners LLC, a US natural gas infrastructure firm, further expanding its energy portfolio in North America.The firm's leadership includes Sheikh Zayed bin Hamdan bin Zayed Al Nahyan as Chairman and Samia Bouazza as CEO. 2PointZero emphasizes the disciplined use of AI and advanced data capabilities to enhance decision-making, unlock new revenue streams, and ensure efficient, responsible growth across its extensive portfolio. The group's strategic focus spans high-growth sectors, including food security, advanced energy, and renewables, with plans to capitalize on demographic shifts and rising demand for consumer goods in emerging markets.

35V

35V

Limited PartnerUnited States

35V is the family office of two-time NBA Champion Kevin Durant and his business partner Rich Kleiman, established in 2016. The firm serves as the hub for Durant's personal brand and business ventures, manages investments in over 100 startups, and oversees the Durant Family Foundation. 35V operates as a family office with a focus on growth and expansion opportunities across various sectors.Co-founded by Kevin Durant and Rich Kleiman, 35V is closely associated with Boardroom, a multi-faceted sports, media, and entertainment company. Boardroom, also co-founded by Durant and Kleiman, produces media content and hosts signature events at the intersection of sports, entertainment, and business. This synergistic relationship allows 35V to leverage deep industry connections and expertise in its investment strategies.The firm's investment portfolio is diverse, spanning more than 100 companies across growth markets such as fintech, artificial intelligence, health and wellness, and media. Notable investments include digital sports network Overtime, cryptocurrency platform Coinbase, delivery service Postmates, and NBA Top Shot by Dapper Labs. 35V has also strategically invested in sports leagues and teams, including the DC Pickleball Team, Paris St-Germain FC, NWSL's Gotham FC, and MLS' Philadelphia Union.While specific team members for the investment arm are not publicly detailed beyond its founders, 35V emphasizes strategic collaboration with partners on initiatives related to strategy, content, and marketing. The firm's approach combines the entrepreneurial vision of its founders with a broad investment mandate, aiming to support innovative companies and emerging sports properties.

3TS Capital Partners

3TS Capital Partners

InvestorAustria450M AUM

3TS Capital Partners is a prominent European technology-focused venture growth investment adviser. The firm specializes in providing expansion capital and buyout funding to high-growth small and medium-sized enterprises (SMEs) across Europe, with a particular emphasis on the DACH, Central and Eastern European (CEE), and Nordic regions. They actively partner with exceptional founders and management teams, offering not only capital but also strategic support, sector expertise, and access to an extensive international network to facilitate cross-border expansion into markets like North America and Asia. The firm's investment strategy is centered on identifying and nurturing companies that are either becoming local or regional leaders or are innovative global challengers in their respective technology domains.Founded in 1998, 3TS Capital Partners has built a track record spanning over 25 years and multiple fund generations. This extensive experience allows them to navigate various market cycles, lead and co-lead significant funding rounds, and drive value creation from the initial investment through to a successful exit. Their multi-vintage funds reflect a consistent approach to partnering with entrepreneurs to scale products globally, strengthen competitive advantages, and deliver strong returns to stakeholders. The firm's culture emphasizes professionalism, analytical rigor, and a collaborative, hands-on approach to supporting its portfolio companies.3TS Capital Partners focuses its investments across several key sectors, including Technology & Internet, Media & Communications, and Technology-Enabled Services. Within these areas, they target innovative companies involved in software, hardware, mobile, cybersecurity, e-commerce, artificial intelligence, digital media, communications platforms, and technology-driven consumer and business service providers, including those in healthcare. Notable investments from their portfolio include companies like Piano, a global leader in digital experience platforms; Tosibox, a leader in secure Operational Technology (OT) networking; and Wealthon, a fintech firm building a digital financial ecosystem for SMEs. Other significant portfolio companies have included NetRetail Holding, MALL.cz, SmartDreamers, Evrotrust, Mavoco, Jentis, and Boksi.The team at 3TS Capital Partners comprises experienced investors and operators with deep industry expertise. Key team members, such as Managing Partners Pekka Mäki, Mihaly Szalontay, and Daniel Lynch, along with Partners Sever Totia, Zbigniew Lapinski, Andreas Huber, and Attila Konya, bring a wealth of knowledge in scaling technology companies internationally. Their collective experience and commitment to long-term engagement enable them to provide strategic guidance, facilitate mergers and acquisitions, and support global expansion strategies for their portfolio companies, fostering growth and innovation within the European technology sector.

Aakash Emprise

Aakash Emprise

InvestorIndia

Aakash Emprise is an investment firm dedicated to cultivating success by supporting and growing impactful businesses. The firm provides both capital investments and strategic guidance to high-potential small and medium-sized enterprises (SMEs) and select start-ups. Their mission is to create meaningful change by fostering businesses that offer impactful solutions while generating long-term value for investors and global communities. Aakash Emprise takes a long-term view on building companies with a positive societal or environmental impact, focusing on sectors essential to society such as education, healthcare, wellness, food, and energy.The firm was founded in 2021 by Mr. Aakash Chaudhry, who brings extensive experience from his role as Co-founder, Managing Director, and CEO of Aakash Educational Services Limited (AESL) until 2023. Prior to his tenure at AESL, Mr. Chaudhry worked with leading IT companies like Infosys Technologies and Cognizant Technology Solutions. Aakash Emprise operates as his family office, through which he makes investments in private and public markets. He is also currently leading Aakash Life, a healthcare, beauty, and wellness retail business, and Sparkl Eduventures Pvt. Ltd., an online tutoring venture.Aakash Emprise's portfolio includes notable investments across various sectors. Key portfolio companies and successful exits include Simplilearn, an online training and professional certification course provider, and VLCC, an operator of wellness and beauty services centers, both of which have been acquired. Other investments include Bombay Shaving, Heyo, Dextres, Xume, Yuno Learning, Plutos ONE, HONO, Inc42, National Stock Exchange of India (NSE), and Xyone. These investments span areas from online education and personal care to financial technology, human capital management, and biotechnology.The team at Aakash Emprise, led by Mr. Aakash Chaudhry, leverages decades of experience in building and growing large enterprises. Mr. Chaudhry's background in education and IT, coupled with his strategic vision, enables the firm to offer tailored advice and comprehensive support to its portfolio companies. The firm emphasizes partnership development, forging strategic alliances with industry experts, investors, and thought leaders to provide resources and mentorship, empowering entrepreneurs to thrive and turn innovative ideas into successful ventures. The team, comprising 7 members including 2 partners and 1 principal, is committed to developing and implementing socially and environmentally responsible practices across all business development areas.

Abacus Finance Group

Abacus Finance Group

LenderUnited States1.4B AUM

Abacus Finance Group is a New York City-headquartered investment firm specializing in providing tailored senior debt credit solutions to lower-middle market companies. The firm primarily partners with private equity- and family office-backed businesses, focusing on those with EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) between $2 million and $15 million. Abacus Finance is known for its cash flow-based senior secured loans, emphasizing speed, transparency, and reliable execution in its financing processes.Founded in 2011 by Tim Clifford and Sean McKeever, Abacus Finance Group has grown significantly, surpassing $2.8 billion in total financing by 2022 and managing approximately $1.4 billion in assets. The firm operates with a "Total Partnership Approach™," aiming to build deep, long-term relationships with its clients and portfolio companies. This approach underscores their commitment to understanding unique needs and working collaboratively throughout the transaction lifecycle.Abacus Finance Group has a diverse portfolio, having invested in over 120 platform companies and facilitated more than 70 add-on acquisitions. Notable transactions include providing senior debt financing for WestView Capital Partners’ investment in Benefits All In and supporting the growth equity investment in Hoist Global Tech Solutions. The firm also engages in equity co-investments, demonstrating a flexible approach to supporting its partners.The firm's core team has remained largely intact since its inception in 2011, bringing over 125 years of combined leveraged finance experience. Key leadership includes CEO & Founding Partner Tim Clifford and President & Founding Partner Sean McKeever. This experienced team is dedicated to integrity, creativity, and continuous improvement, ensuring a consistent and high-quality partnership experience for their clients.

Accolade Partners

Accolade Partners

InvestorUnited States9.0B AUM

Accolade Partners is a prominent alternative asset platform established in 2000, specializing in fund-of-funds investments across venture capital, growth equity, and blockchain strategies. The firm primarily targets the technology and healthcare sectors, seeking to construct concentrated portfolios of difficult-to-access funds. They also engage in selective direct co-investments alongside their roster of fund managers, aiming to enhance their fund's overall strategy.Founded by Joelle Kayden, Accolade Partners has grown to manage billions in assets, serving a diverse investor base that includes endowments, foundations, family offices, and institutional investors. The firm's investment approach emphasizes independent thinking, disciplined strategy, and a focus on building high-quality, complementary portfolios. Joelle Kayden's extensive background in technology investment banking, including her role as the first CFO of ABS Ventures, laid the groundwork for Accolade's establishment and its enduring focus on the venture ecosystem.Accolade Partners has a history of investing in underlying funds that back notable companies. While primarily a fund-of-funds, their portfolio has seen indirect exposure to entities such as Andreessen Horowitz, Accel, and Kleiner Perkins. Direct investments have included companies like Avant, KnowBe4, Acquia, TigerConnect, eHealth Technologies, A Cloud Guru, and Sun Basket, spanning sectors like enterprise applications, enterprise infrastructure, and consumer technology.The firm's team, led by founding and managing partner Joelle Kayden, includes experienced professionals such as Caitlin Mulligan (Partner, General Counsel), Meera Patel (Partner), and Andrew Salembier (Partner, COO). The team's collective expertise spans investment management, legal and compliance, and operations, enabling Accolade Partners to identify and partner with top-tier fund managers and navigate complex investment landscapes.

Aceana Group

Aceana Group

InvestorUnited States

Aceana Group is a distinguished single-family office (SFO) based in the United States, specializing in private investments across a broad range of asset classes. The firm focuses on venture capital, private equity, real estate, and infrastructure, with a particular emphasis on innovative, technology-driven companies and strategies. Since the onset of the pandemic, Aceana Group has strategically deployed capital in 16 funds and more than 50 direct and co-investments, demonstrating a commitment to long-term value creation and industry transformation.The firm was founded in 2006 and operates under the leadership of seasoned investment professionals. Aceana Group is committed to identifying high-growth opportunities across various emerging sectors, leveraging the extensive experience of its team in alternative assets and international capital markets.Aceana Group's investment strategy includes a strong interest in impact investing and Environmental, Social, and Governance (ESG) funds. Their technology and innovation focus spans areas such as Blockchain, Crypto, Artificial Intelligence (AI), Deep Tech, Life Sciences, Digital Health, PropTech, EdTech, and MedTech. While specific portfolio companies are not publicly listed, the firm's activity in numerous funds and direct/co-investments highlights its active role in these sectors.The leadership team includes Russell Deakin, CIO and Managing Partner, who brings over 25 years of global experience in alternative assets, including private equity, venture capital, real estate, infrastructure, and renewable energy. His expertise covers entrepreneurial ventures, blockchain, crypto, growth capital, and international capital markets. Aaruni Kumar serves as Executive Director, leading due diligence and portfolio management for technology investments, with a focus on AI, mobility, and telecom infrastructure.

A

Adi Family Office

InvestorUnited States

Adi Family Office (AFO) is a single-family office established by technology entrepreneurs, based in Dallas, Texas. The firm is dedicated to investing across a diverse range of asset classes, including public and private equity, debt, real estate, and venture opportunities. Their investment philosophy centers on generating alpha returns through strategic investments in an innovative portfolio, both domestically and in emerging global hubs.Founded in 2012, Adi Family Office was established by Adil Adi and his family with a mission to improve the quality of life for humanity through their investments. The firm's venture capital portfolio includes promising research, technologies, and entrepreneurs, particularly those driving new discoveries in technology and life sciences.The firm targets technology and digital transformation across various sectors, including healthcare, financial services, and media entertainment. They also show a preference for life-science startups driven by technology and engineering, such as new drug-delivery systems. Notable areas of interest include Digital Health, Healthtech, Medtech, Security, and Software Technologies.Adi Family Office is part of the broader ADI Group, which also includes WorldLink, an IT Services leader focused on 5G, cloud, AI/ML, application development, IoT, and blockchain, and Inspired Intellect, an end-to-end service provider for data management, analytics, and application development. This affiliation highlights the firm's deep roots and expertise in technology and innovation.

Adit Ventures

Adit Ventures

InvestorUnited States419.84953M AUM

Adit Ventures is a New York-based venture capital firm established in 2014, specializing in late-stage, privately held, venture-backed businesses. The firm focuses on identifying attractive pre-IPO opportunities that align with significant secular growth trends. Their investment strategy is underpinned by a thematic approach, combining bottom-up fundamental analysis with a long-term investment horizon of three to five years. Adit Ventures aims to provide investors, including family offices and institutions, access to high-growth private companies by acquiring both primary and secondary shares from a global network of relationships.The firm was co-founded by Eric Munson, who serves as the Chief Investment Officer and Managing Partner. Adit Ventures Management, LLC, the investment management entity, was founded in 2016 by Eric Munson and Daniel McCooey. Munson, with over four decades of experience in financial services, established Adit Ventures to democratize access to innovative, late-stage growth companies that are increasingly remaining private for longer periods before a liquidity event. The firm emphasizes ethical, mission-driven investing, seeking to generate healthy returns while making a positive impact.Adit Ventures has built a diverse portfolio of notable companies across various high-growth sectors. Key investments include prominent names such as SoFi, Lyft, Robinhood, Airbnb, Spotify, Palantir, Turo, Flexport, Netskope, Rubrik, Animoca Brands, Noom, Phenom, r4 Technologies, Somo, ImmunoGenesis, Azarus, Playter, and Fictiv. These investments span industries driven by artificial intelligence, financial technology, cloud computing, health-tech, defense-tech, space technology, big data, cybersecurity, and the shared economy.The team at Adit Ventures brings a wealth of experience to their investment activities. Led by Eric Munson, the firm's leadership includes professionals like Tom Munson, Justin Dennis, Constantinos Petrides, and Jon Cholak, who joined as Managing Director and Portfolio Manager to expand the firm's early-stage venture platform, Adit Genesis. The team's collective expertise in venture capital, corporate finance, and alternative asset management enables them to conduct thorough diligence and provide insights on market trends, fostering strong partnerships with both portfolio companies and investor partners.

A

Advent International

InvestorBrazil94.0B AUM

Founded in 1984, Advent International is one of the largest and most experienced global private equity firms. With decades of industry leadership, it has established a strong track record of successful investments and deep sector expertise. Advent has invested in over 420 private equity transactions across 43 countries. The firm partners with management teams to accelerate growth through strategic support, operational improvement, and long-term vision alignment. With $94 billion in assets under management as of December 31, 2023, Advent primarily focuses on buyouts and growth equity investments across five key sectors, maintaining a flexible and globally integrated approach.

AIM13

AIM13

InvestorUnited States1.7B AUM

AIM13, also known as Alternative Investment Management, LLC, is an independent, privately-held, and owner-operated investment management firm. Registered with the Securities and Exchange Commission as an Investment Adviser since 2012, the firm partners with a diverse range of investors, including individuals, family offices, foundations, endowments, corporate and public pension plans, and other tax-exempt entities. AIM13 emphasizes a thoughtful approach to investing across various asset classes, striving to provide a competitive edge to its partners through distinct, dynamic partnerships, extensive due diligence protocols, and powerful networks. The firm invests alongside its partners, offering its considerable investment experience, comprehensive due diligence, and transparency to facilitate access to what it considers the industry’s most sought-after investment professionals.The firm's origins date back to 1999, when two families initiated a partnership primarily focused on private equity and hedge fund strategies. By 2003, AIM13 strategically expanded its network by incorporating value-add partners, including CEOs, heads of private equity firms, finance professionals, lawyers, bankers, and former government officials. This expansion significantly enhanced their sourcing, access, and due diligence capabilities. In 2006, the firm began accepting tax-exempt capital, attracting investments from foundations, endowments, pensions, and non-US partners. AIM13 manages approximately $1.7 billion in assets, with over 20% of this capital originating from internal and affiliated individuals, demonstrating a strong alignment of interest with its partners.AIM13 specializes in providing selective, integrated exposure to a variety of investment strategies. Their investment focus spans private equity, hedge funds, real estate, and credit opportunities. The firm is recognized for its rigorous due diligence and unique access to investment professionals, particularly in areas involving dual-use technologies and government contracting, as evidenced by their strategic advisors' backgrounds. They seek opportunities across diverse sectors including aerospace & defense, technology, healthcare, financial services, energy, consumer, business services, and materials. The firm's culture is deeply rooted in fostering an ultimate alignment of interest among itself, its partners, and the investment professionals with whom they collaborate.The team at AIM13 comprises experienced professionals, including Jonathan Harris as CEO, and partners Diana Cantor, Susan Mays, Peter Brown, and Phil Villhauer. Seth Rosenblatt serves as Chief Financial Officer. The firm also benefits from a CIO Advisory Council and Senior Advisors, such as retired Four-Star General Scott Miller, former CIA Officer Alec Bierbauer, and former CIA Chief Information Security Officer Robert Bigman, whose expertise contributes to the firm's differentiated insights, particularly in areas like government and commercial customer connectivity for dual-use technologies.

AJU IB Investment

AJU IB Investment

InvestorSouth Korea2.5M AUM

AJU IB Investment is a prominent South Korean venture capital and private equity firm, established in 1974 as the nation's first venture capital company. The firm has a long-standing track record of supporting innovative companies across various stages of their lifecycle, from early-stage startups to pre-IPO and post-IPO phases. With a cumulative managed fund exceeding KRW 3.2 trillion over the past two decades, AJU IB Investment demonstrates both stability and profitability, having successfully liquidated 38 funds. They are also pioneers in South Korea for endorsing the TCFD and adopting an ESG investment approach since 2021, emphasizing a sustainable venture ecosystem.The firm's investment strategy is multi-faceted, encompassing venture capital and private equity investments. While AJU IB Investment broadly targets sectors such as healthcare, technology, information technology (including mobile service platforms, software, semiconductors, and AI), biotechnology, life science, and environment sectors, its U.S. subsidiary, Solasta Ventures, has a more specialized focus. Solasta Ventures, incorporated in 2019 from AJU IB Investment's Americas office established in 2013, primarily invests in pharmaceutical and biotech startups from its Boston headquarters, with a Silicon Valley branch focusing on AI, cloud, big data, robotics, and autonomous driving.AJU IB Investment and its subsidiary Solasta Ventures actively seek to invest in companies that advance the standard of care for diseases with unmet medical needs, leveraging deep scientific expertise and an extensive network. Their portfolio includes investments in therapeutics, drug development, cell therapy, and genetic medicines, with a particular interest in oncology, neurology, and immunology. Solasta Ventures has shown impressive investment results, with 19 of its 38 invested companies being listed on NASDAQ by June 2023, acting as a crucial bridge between American startups and Korean companies.The leadership team includes Jiwon Kim as the CEO of AJU IB Investment, overseeing the firm's comprehensive investment strategies. Derek Yoon serves as the President & CEO of Solasta Ventures, leading its U.S. investments with a focus on life science companies and early-stage startups with novel science. The team's collective experience in healthcare investments and drug development, coupled with a scientific advisory board, underpins their ability to identify and nurture promising ventures globally.

Ally Bridge Group

Ally Bridge Group

InvestorUnited States1.4B AUM

Ally Bridge Group is a global healthcare investment management firm that focuses on high-impact life science innovation across both private and public markets. The firm employs a dual strategy, encompassing private equity and public equity, to invest across the global healthcare industry and various points of the capital structure. Their mission is to deliver superior risk-adjusted returns for investors by identifying and supporting innovations that address unmet medical needs. This approach is underpinned by a blend of deep scientific and clinical research, combined with extensive expertise in mergers and acquisitions and capital markets.The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. Prior to establishing Ally Bridge Group, Frank Yu founded Themes Investment Partners in 2009. His extensive background includes leadership roles at Sculptor Capital Management (formerly Och-Ziff Capital Management) as Managing Director and Head of China Investments, and nearly a decade at Goldman Sachs in various capacities, including Investment Banking and Head of Principal Investment Origination. Ally Bridge Group manages assets from its offices in New York and Hong Kong, leveraging a global franchise to source and secure opportunities in life science innovation.Ally Bridge Group has been a lead or co-lead investor in over $6 billion of transactions across healthcare subsectors. Their investment portfolio includes companies such as First Tracks Biotherapeutics, Calyxo, and Imperative Care, operating in industries like Drug Discovery and Surgical Devices. Other notable investments include ProMIS Neurosciences, Biobeat, GRAIL, BeiGene, and Elligo Health Research. The firm actively seeks opportunities in innovative and potentially disruptive technologies and products, with a particular focus on later-stage development for venture deals and companies with global potential for growth equity.The firm's leadership and investment team bring diverse and specialized expertise to their strategies. Frank Yu guides the firm's strategic initiatives and investment objectives globally. The team includes Managing Directors like Kevin Reilly, Head of Medtech Private Equity, and Andrew Lam, Head of Biotech Private Equity, both of whom joined in 2021. Carlos Solorzano, a Principal in Private Equity, joined in 2024, bringing experience from Section 32 and Pivotal bioVenture Partners. Zain Shekhani serves as Managing Director, Head of Investor Relations for the private equity strategy, while Srishti Kotiyal is an Associate focused on biotech investments. This collective expertise in scientific research, clinical development, and financial markets enables Ally Bridge Group to identify and capitalize on high-impact investment opportunities.

A

Alpha Wave Ventures

InvestorUnited States19.4B AUM

Alpha Wave Global, originally established as Falcon Edge Capital in 2012, is a prominent global alternative asset manager. The firm operates across various verticals, including private equity, private credit, public markets, and venture capital, with a strategic focus on growth and expansion-stage companies worldwide. Alpha Wave Global aims to be a long-term partner to founders and management teams, providing both capital and strategic guidance to foster company growth and innovation.The firm was founded by Rick Gerson, Navroz D. Udwadia, and Ryan Khoury. Rick Gerson, who serves as Co-Founder, Chairman, and Chief Executive Officer, previously held a significant role as a Founding Member and Managing Director at Blue Ridge Capital for 15 years. Alpha Wave Global manages a series of funds, including Alpha Wave Ventures and Alpha Wave Incubation, targeting diverse investment opportunities globally.Alpha Wave Global has built an extensive portfolio of over 200 investments, backing high-profile companies such as SpaceX, Lenskart, and Ola Electric. Other notable investments include Advanta Seeds, Metsera, ZEDEDA, HiBob, Anthropic, Hunch, and the Mensa Group. The firm's investment strategy spans a wide array of sectors, including information technology, fintech, artificial intelligence (AI), life sciences, consumer internet, B2B sectors, cultivation, drug discovery, business/productivity software, agritech, biotech, energy & utilities, hardware, robotics & IoT, legal & professional services, pharma, real estate & proptech, sharing economy, software & apps, food products, and healthcare.With offices in major global hubs such as New York, Miami, London, Abu Dhabi, Tel Aviv, Bangalore, Jakarta, Sydney, Mumbai, and New Delhi, Alpha Wave Global manages approximately $19.4 billion in assets under management as of December 31, 2024. The firm's approach emphasizes identifying and supporting companies that are poised to disrupt industries and create significant value.

A

AltamarCAM Partners

InvestorChile22.5B AUM

AltamarCAM Partners is an independent, partner-led private asset manager founded in 2004 and headquartered in Madrid, Spain. The firm specializes in providing institutional investors—including insurance companies, pension funds, and financial institutions—as well as high-net-worth individuals, with access to global alternative investments across private equity, venture capital, life sciences, real assets (real estate and infrastructure), and private debt/credit. Their investment strategies encompass primaries, secondaries, and co-investments, tailored to meet diverse client needs. With over €20.8 billion in assets under management, AltamarCAM operates through a network of specialized entities, including Altamar Private Equity, Altan Capital, and Altamar Advisory Partners. These subsidiaries enable the firm to offer a comprehensive suite of services, from fund management to independent financial advisory and merchant banking. The firm's global presence includes offices in Madrid, Barcelona, Munich, Cologne, London, New York, and Santiago de Chile, supported by a team of more than 350 professionals. AltamarCAM is committed to delivering long-term value through a disciplined investment approach and a strong focus on environmental, social, and governance (ESG) principles. Their diversified portfolio and strategic partnerships, such as the recent collaboration with Mirabaud to launch an evergreen semi-liquid private equity strategy, underscore their dedication to innovation and client-centric solutions in the private markets.

American Securities

American Securities

InvestorUnited States18.9B AUM

American Securities is a leading U.S. private equity firm that partners with existing management teams to invest in and grow market-leading businesses. The firm focuses on generating superior returns for its investors by taking a long-term, strategic approach to value creation. Their investment philosophy emphasizes honesty, true partnership, respect, and a commitment to fostering an inclusive environment. American Securities typically targets North American companies with annual revenues generally ranging from $200 million to $2 billion and/or $50 million to $250 million of EBITDA.The firm's origins trace back to a family office founded in 1947 by William Rosenwald, an heir to the Sears, Roebuck & Co. fortune. In 1994, under the leadership of Michael Fisch, American Securities opened its private equity investment activities to outside investors, establishing itself as a prominent player in the private equity landscape. Since then, the firm has built a strong track record of value creation, completing numerous platform investments and add-on acquisitions across various funds.American Securities boasts a diverse portfolio spanning a wide array of industries. Notable past and current investments include companies in sectors such as industrials (e.g., Acuren, Integrated Global Services), manufacturing (e.g., Advanced Drainage Systems, Chromaflo Technologies, Tekni-Plex), business services (e.g., Aramsco, Presidio), healthcare (e.g., The Aspen Group, SpecialtyCare), consumer products (e.g., El Pollo Loco, Milk Specialties Global), technology (e.g., Trace3, NWN Carousel), education (e.g., Learning Care Group, FullBloom), materials and chemicals (e.g., Hexion, Prince, Vibrantz Technologies), energy infrastructure (e.g., SOLV Energy, Delphi Midstream Partners), and aerospace & defense (e.g., Amentum, Robertson Fuel Systems).The firm's team comprises experienced professionals across investment, capital markets, resources, strategy, operations, human capital, IT, data science, financial performance, ESG, investor relations, legal, compliance, tax, and human resources. This extensive internal expertise allows American Securities to provide comprehensive support to its portfolio companies, working closely with management teams to develop and implement strategic initiatives, drive operational improvements, and achieve long-term success.

Apax Global Impact

Apax Global Impact

InvestorUnited Kingdom900M AUM

Apax Global Impact is an investment firm dedicated to supporting companies that deliver measurable societal and/or environmental impact. As a distinct strategy within the broader Apax Partners platform, it leverages the firm's extensive sector expertise and operational capabilities to drive transformational outcomes for both people and the planet. The firm focuses on identifying and partnering with visionary businesses whose core products and services address critical global challenges, aligning its investment approach with the United Nations Sustainable Development Goals (UN SDGs).The Apax Global Impact strategy was officially launched in November 2021, building upon Apax Partners' long-standing commitment to sustainability and responsible investing, which dates back to its co-founder Sir Ronald Cohen, an impact investing pioneer. The firm's approach integrates a robust and proprietary impact measurement system, developed with internal and external experts, to evaluate and monitor impact throughout the investment lifecycle. This rigorous framework helps identify and track outcomes across its portfolio companies, ensuring both financial and impact returns are optimized.Apax Global Impact targets investments across four key sector themes: Health & Wellness, Climate, Environment & Resource Efficiency, Social & Economic Mobility, and Digital Impact Enablers. Notable investments include companies like Foods Connected (business/productivity software), GAN Integrity (supply chain risk-management software), Swing Education (an online marketplace connecting schools and substitute teachers), Bonterra (social good software), and Eating Recovery Center (a provider of eating disorder treatment). These investments demonstrate the firm's commitment to diverse solutions that address pressing social and environmental issues.The dedicated Apax Global Impact team, co-led by Managing Partners Alykhan Nathoo and David Su, comprises experienced investment professionals supported by an Impact Advisory Board of industry experts. This team benefits from the broader Apax platform's global reach, deep sub-sector knowledge in technology, services, and internet/consumer, and the value creation potential of Apax's Operational Excellence Practice. This integrated approach allows Apax Global Impact to provide specialist insights, reduce execution risk, accelerate growth, and expand margins for its partner companies.

Apeiron Ventures

Apeiron Ventures

InvestorUnited States

Apeiron Ventures is a private investment office and family-owned investment company based in New York, focusing on opportunistic direct investments. The firm partners with founders and companies that are actively transforming the way society builds, consumes, and learns. Their investment philosophy centers on collaborating with exceptional individuals to achieve extraordinary results, providing bespoke solutions and strategic operating guidance to entrepreneurs and investment partners. Apeiron Ventures leverages its permanent flexible capital and streamlined decision-making process to act swiftly on promising opportunities.Founded in 2017, Apeiron Ventures operates with a history rooted in entrepreneurship, operations, and investment. The firm positions itself as strategic capital, utilizing its extensive background and network to navigate the challenges faced by fast-growing companies. They are committed to supporting entrepreneurs who are building the next generation of businesses that address contemporary societal issues, recognizing these innovators as the future business leaders.The firm's investment mandate includes companies creating innovative products and services across significant markets such as real estate, agriculture, and transportation, as well as those pursuing advancements in human health and wellness. Notable investments by Apeiron Ventures include Lyft, a prominent app-based ride-hailing aggregator, Rubicon Global, a company focused on waste and recycling solutions, Bluon Energy, an energy efficiency firm, Prodea, and Aquaai, which develops robotic fish for water resource protection using AI and biomimicry.The Apeiron Ventures team brings a wealth of experience to its investment activities. David Nage serves as Managing Director, with a decade of experience in the Family Office community, focusing on illiquid investments in venture capital, private equity, and direct investments with a sustainable/impact focus. Jack Fattal, an Associate, contributes a multi-dimensional background as both a lawyer and an entrepreneur. Bill Teitelbaum, an Advisor, has a distinguished career in investment banking, private equity, and as a founder of multiple successful companies, including underwriting one of the original VC funds in the United States.

Introduction to Healthcare Private Equity Firms in North America

The healthcare sector presents a myriad of investment opportunities characterized by innovation, growth potential, and resilience. Healthcare private equity firms in North America are at the forefront of capitalizing on these opportunities, offering investors access to a dynamic and essential industry. This curated directory of 36 esteemed investors provides a comprehensive overview for limited partners (LPs) and deal professionals seeking to engage with firms that specialize in healthcare investments.

Investment Strategies and Focus Areas

Typical Investment Strategies

Healthcare private equity firms typically employ a variety of strategies tailored to maximize returns while managing risks associated with the sector. Common approaches include buyouts, growth capital, and venture investments. These firms often focus on acquiring or investing in companies that demonstrate strong potential for scalability, innovation, and market leadership. They seek to create value by enhancing operational efficiencies, driving strategic growth initiatives, and navigating complex regulatory environments.

Focus Areas in Healthcare

Investment focus areas for these firms are diverse and span across various segments of the healthcare industry. Popular areas include pharmaceuticals, medical devices, healthcare IT, and provider services. Many firms are particularly keen on sectors that benefit from demographic trends such as an aging population, increased prevalence of chronic diseases, and the growing demand for personalized medicine. By concentrating on these high-impact areas, firms aim to capitalize on long-term growth trends while contributing to advancements in healthcare delivery.

Geographic Presence and Influence

North American Market Insights

North America remains a prime region for healthcare private equity investments due to its robust healthcare infrastructure, innovative ecosystem, and regulatory environment conducive to business growth. These firms are predominantly based in major financial hubs, including New York, San Francisco, and Toronto, allowing them to leverage local expertise and networks. Their geographic presence enables them to identify and seize investment opportunities across the continent, thereby enhancing their influence within the industry.

Global Reach and Expansion

While primarily focused on North America, many healthcare private equity firms are also expanding their investment horizons globally. This expansion is driven by the desire to access emerging markets with significant growth potential and to diversify investment portfolios. By tapping into international markets, these firms can leverage global healthcare trends and innovations, further solidifying their position as leaders in healthcare investments.

Relevance for LPs and Deal Professionals

For LPs and deal professionals, understanding the landscape of healthcare private equity firms in North America is crucial for informed decision-making. These firms offer a unique opportunity to invest in an essential sector with promising returns. By engaging with firms in this directory, LPs can gain access to specialized expertise, strategic partnerships, and a diversified investment portfolio that aligns with their financial objectives.

Deal professionals, on the other hand, benefit from collaborating with healthcare-focused private equity firms by gaining insights into industry trends, regulatory impacts, and innovative business models. Such partnerships enable them to structure deals that are not only financially rewarding but also contribute to the advancement of healthcare solutions.

Conclusion

The directory of healthcare private equity firms in North America serves as a vital resource for investors and professionals seeking to navigate the complex landscape of healthcare investments. With a strategic focus on innovation, growth, and geographic expansion, these firms are well-positioned to drive significant value in an ever-evolving industry. Engaging with these investors allows stakeholders to participate in transformative healthcare solutions, ultimately contributing to the betterment of global health outcomes.